Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection

NCT01435044 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

239

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Sofosbuvir
DRUG: GS-0938
DRUG: RBV
DRUG: Placebo to match sofosbuvir
DRUG: Placebo to match GS-0938

Sponsor

Gilead Sciences

Collaborators

[object Object]